Conference Call to be on Friday, November 11, at 4:15 PM ET
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to
file Form 10-K for the 2016 fiscal year ended August 31, 2016, with the
U.S. Securities and Exchange Commission on November 14, 2016.
Walt Woltosz, chairman and CEO, and Ted Grasela, president, will host a
conference call to discuss the Company’s performance on Friday, November
11, 2016, at 4:15 p.m. Eastern Time. All interested parties are invited
to join the call by registering at: https://attendee.gotowebinar.com/register/7098520015199435521.
On registering, you will receive a confirmation e-mail with instructions
for joining the call. Please dial in five to ten minutes prior to the
scheduled start time. For listen-only mode, you may dial +1 (415)
930-5321, and enter access code: 591-425-045.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of drug discovery and
development software as well as a leading provider of both preclinical
and clinical pharmacometric consulting services for regulatory
submissions. The company is a global leader focused on improving the
ways scientists use knowledge and data to predict the properties and
outcomes of pharmaceutical and biotechnology agents. Our software is
licensed to and used in the conduct of drug research by major
pharmaceutical and biotechnology companies and regulatory agencies
worldwide. Our innovations in integrating new and existing science in
medicinal chemistry, computational chemistry, pharmaceutical science,
biology, and physiology into our software have made us the leading
software provider for physiologically based pharmacokinetic modeling and
simulation. For more information, visit our website at www.simulations-plus.com.